Browsing Tag

April 2020

General Information, Hemostasis/Coagulation

Test Update: D-Dimer

Effective April 30, 2020, Spectrum Health Laboratories will no longer be performing the D-Dimer Semi-Quantitative assay. D-Dimer (quantitative) will be the only orderable for the D-Dimer assay. This D-Dimer will be reportable up to 35,000 ng/mL FEU. The cut-off value used in the diagnosis of venous thromboembolism (VTE), deep vein thrombosis (DVT), or pulmonary embolism (PE) remains at 500 ng/mL FEU. It is important to note inpatients can be (falsely) elevated in many underlying non-thrombotic conditions common in hospitalized patients.

Questions and inquiries regarding this change may be sent to the Coagulation Department using the “Contact Us” link above.

 

TEST INFORMATION

D-Dimer – [Epic Code: LAB313, Interface Code: 10123, CPT 85379]

Discontinued: D-Dimer Semiquantitative for DIC [Epic Code: LAB760, Interface Code: 10122, CPT: 85378]

General Information, Immunochemistry

Immunochemistry ANA (Antinuclear Antibodies) Testing Name Update

Effective April 22nd, 2020, the following ANA (Antinuclear Antibodies) Tests’ name will be updated.  The change in naming convention comes in hopes of enhancing proper test utilization.  This update includes only the name change with no changes in laboratory testing workflow.

Old Test Name New Test Name Test Code Clinical Utility
ANA (Antinuclear Antibodies) Screen, Double Reflex to ANA IFA Hep2 Titer and Pattern, and if positive to ANA antibodies ANA screen LAB1230491 Preferred initial ANA screen for autoimmune connective tissue diseases.
ANA (Antinuclear Antibodies), Hep2 Substrate IFA with reflex to Titer and Pattern if positive IFA ANA (Rheumatology)

 

LAB3540 Preferred confirmatory ANA test for autoimmune connective tissue diseases.  With ordering recommendations for rheumatology only.
Advanced Technology Laboratory, Education & Training, General Information, Referral/Sendouts

Covid-19 Information

New posts will appear below this post.

Updated 6/25/20

Spectrum Health Laboratories is accepting COVID test orders from Spectrum Health and outside providers. For additional information, please refer to our Outpatient Provider Office Collection Information Packet. This packet contains ordering and supply information as well as other related information. 

•Spectrum Health Laboratory offers nasal self-collection observation at select draw sites.
•If you’re interested in having your patient tested via nasopharyngeal swab and you cannot collect specimens in your office, please direct your patient to the screening hotline: 833.559.0659. Screening is required before COVID collection and testing can occur for the hotline.

Providers: COVID-19 testing criteria:

LINK: Symptoms of COVID-19  (CDC guidelines)

LINK: Testing criteria (CDC guidelines)

Facilities: If you would like to receive testing for your staff and/or residents please follow these instructions:

•Call: 616-486-1075 or

•Email: covidemployerhotline@spectrumhealth.org

Outpatient Draw Site Hours:

Outpatient draw site hours and availability may have changed. Please refer to Find-A-Doc for more information.

• Link: Find-A-Doc Location

Preferred Collection:

Nasopharyngeal (NP) swabs are the preferred specimen type.

Link: Nasopharyngeal Collection

If NP swabs cannot be collected, anterior nasal swabs may be collected as an alternative with slightly reduced sensitivity.

New Test: COVID-19 IgG Antibody – Serology test

Continue Reading